News that approval from the FDA of the Dexcom G7 15 day CGM in the US, with a grace period of 12 hours, makes this the longest lasting CGM.
Dexcom's financial filings reveal a warning letter from the FDA regarding processing in 2 of its manufacturing plants.
News that Abbott and Dexcom have agreed not to sue each other for patents relating to their CGM tech for another 10 years.
